Geode Capital Management, LLC Dbv Technologies S.A. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Dbv Technologies S.A. stock. As of the latest transaction made, Geode Capital Management, LLC holds 38,779 shares of DBVT stock, worth $32,574. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,779
Previous 38,779
-0.0%
Holding current value
$32,574
Previous $36,000
19.44%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding DBVT
# of Institutions
35Shares Held
37.7MCall Options Held
0Put Options Held
0-
Baker Bros. Advisors LP New York, NY14.6MShares$12.3 Million0.14% of portfolio
-
Braidwell LP Stamford, CT7.84MShares$6.59 Million0.19% of portfolio
-
Yiheng Capital Management, L.P. San Francisco, CA5.57MShares$4.68 Million0.23% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.11MShares$2.61 Million0.01% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.71MShares$2.28 Million0.27% of portfolio
About DBV Technologies S.A.
- Ticker DBVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,776,992
- Market Cap $158M
- Description
- DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...